Free Trial

Greater Cannabis (GCAN) Competitors

Greater Cannabis logo
$0.0002 0.00 (-33.33%)
As of 11:55 AM Eastern

GCAN vs. ATNFW, LBPSW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CALA, and CELUW

Should you be buying Greater Cannabis stock or one of its competitors? The main competitors of Greater Cannabis include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Greater Cannabis vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Greater Cannabis (NASDAQ:GCAN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Greater CannabisN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Greater Cannabis N/A N/A N/A

In the previous week, Greater Cannabis' average media sentiment score of 0.45 beat 180 Life Sciences' score of 0.00 indicating that Greater Cannabis is being referred to more favorably in the news media.

Company Overall Sentiment
180 Life Sciences Neutral
Greater Cannabis Neutral

Summary

Greater Cannabis beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Greater Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCAN vs. The Competition

MetricGreater CannabisDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.73B$6.11B$10.53B
Dividend YieldN/A2.94%5.51%4.67%
P/E RatioN/A117.6685.7226.89
Price / SalesN/A1,535.00580.63183.63
Price / CashN/A10.3726.3031.10
Price / BookN/A11.5313.236.68
Net IncomeN/A$20.70B$3.30B$276.44M
7 Day PerformanceN/A0.72%4.85%3.12%
1 Month PerformanceN/A3.65%8.50%10.19%
1 Year PerformanceN/A8.36%87.78%40.24%

Greater Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCAN
Greater Cannabis
N/A$0.00
-33.3%
N/A-25.0%$0.00N/A0.001Gap Down
ATNFW
180 Life Sciences
N/A$0.07
+13.8%
N/A+646.9%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AIMDW
Ainos
N/A$0.18
-21.1%
N/AN/A$0.00$110.87K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.45
+8.2%
N/A-56.0%$0.00$560.10M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-22.8%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.09
-8.4%
N/A+420.4%$0.00$39.19M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
-2.2%
N/A-98.6%$0.00$199.07M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.04
+9.3%
N/A-87.9%$0.00N/A0.008Short Interest ↑
Gap Down
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-40.0%$0.00N/A0.0060
CELUW
Celularity
N/A$0.04
+17.4%
N/A+198.0%$0.00$44.59M0.00220Positive News
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:GCAN) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners